Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody
Seckinger A, Buatois V, Moine V, et al. Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody[J]. Frontiers in Immunology, 2024, 15: 1378813.
Used in this study: B-hSIRPA/hCD47 mice
Read entire article